Trial Profile
Phase 2 Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers: A Randomized, Comparator-controlled, Single-blind, Parallel-group, Multi-center Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Adipose stem cell therapy Anterogen (Primary)
- Indications Diabetic foot ulcer
- Focus Therapeutic Use
- Sponsors Anterogen
- 30 Aug 2017 Status changed from recruiting to completed.
- 04 Dec 2015 New trial record